Latham & Watkins represented Southern California Gas Company in the offering. Southern California Gas Company, an indirect subsidiary of Sempra Energy, closed on March 14, 2022 its...
Southern California Gas Company’s $700 Million Notes Offering
Travere Therapeutics’ $275 Million Convertible Senior Notes Offering
Latham & Watkins represented the underwriters in the offering. Travere Therapeutics, Inc. executed its offering of US$275 million aggregate principal amount of 2.25% convertible senior notes due...
Lumentum’s $750 Million Convertible Senior Notes Offering
Latham & Watkins represented the initial purchasers, Goldman, Sachs & Co. LLC and BofA Securities, Inc., in the offering. Lumentum Holdings Inc. has announced the pricing...
Peabody’s $275 Million Convertible Senior Notes Offering
Latham & Watkins represented the initial purchasers in the offering. Peabody, a leading coal producer, has announced the pricing of its offering of US$275,000,000 aggregate principal amount...
Amgen’s $4 Billion Senior Unsecured Notes Offerings
Latham & Watkins represented Amgen in the offerings. Amgen Inc., one of the world’s leading biotechnology companies, priced on February 17, 2022, a senior unsecured notes...
Spirit Airlines’ $6.6 Billion Merger with Frontier Airlines
Debevoise & Plimpton advised Spirit Airlines, while Latham & Watkins represented Frontier in the transaction. Fried Frank acted as counsel to Citigroup Global Markets Inc. as...
Wolfspeed’s $650 Million Convertible Senior Notes Offering
Latham & Watkins represented Wolfspeed, while Davis Polk advised the representatives of the initial purchasers in the offering. Wolfspeed, Inc., a global leader in the worldwide...
Oscar Health’s $305 Million Convertible Senior Notes Offering
Latham & Watkins represented Oscar Health in the offering. Oscar Health, Inc., the first health insurance company built on a full stack technology platform, has announced a...
Coherus BioSciences’ $300 Million Credit Financing with Pharmakon Advisors
Latham & Watkins represented Coherus in the transaction. Coherus BioSciences, Inc. (Coherus or the Company) (Nasdaq: CHRS) has entered into a loan agreement with investment funds managed...
Arco Platform’s $150 Million Investment Round
Latham & Watkins represented Dragoneer in the transaction. Arco Platform Limited, or Arco (Nasdaq: ARCE), has entered into agreements led by affiliates of Dragoneer Investment Group LLC...
Stem’s $400 Million Green Convertible Senior Notes Offering
Latham & Watkins represented the initial purchasers in the offering. Stem, Inc. executed its US$400 million aggregate principal amount of 0.50% Green Convertible Senior Notes due 2028 in...
DigitalOcean’s $1.5 Billion Convertible Senior Notes Offering
Latham & Watkins represented the initial purchasers in the offering. DigitalOcean Holdings, Inc. finalized its offering of US$1.5 billion aggregate principal amount of 0% convertible senior notes...